Skip to main content
. Author manuscript; available in PMC: 2024 Mar 8.
Published in final edited form as: Brain Res Bull. 2024 Jan 20;207:110885. doi: 10.1016/j.brainresbull.2024.110885

Table 1.

Clinical parameters of TNFR2 agonism in EAE females indicate reduced cumulative motor disease and delayed onset. The day of motor deficit onset was defined as the first day when a mouse scored at least 2 for two consecutive days. The cumulative disease index (CDI), which was calculated as the sum of clinical scores between days 10 and 30, represents a measure for disease severity over time.

Females Males
Vehicle p53-sc-mTNFR2 Sign. Vehicle p53-sc-mTNFR2 Sign.
CDI 40.25 26.25 * **p < 0.001 20.88 21.88 n.s.
n = 17 n = 15 n = 10 n = 12
Day of Onset 15.00 18.00 * *p < 0.01 19.50 21.00 n.s.
n = 17 n = 15 n = 10 n = 12